Publications by authors named "Patrick Netter"

Claim this Profile
A
Advanced combination therapy in inflammatory bowel disease.
Caroline Morizot, Léa Sequier, Jean-Yves Jouzeau, David Moulin, Patrick Netter

Joint Bone Spine· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment sequencing in inflammatory bowel disease: Towards clinical precision medicine.
Léa Sequier, Bénédicte Caron, Sailish Honap, Ludovic Caillo, Romain Altwegg, Patrick Netter

Best Pract Res Clin Gastroenterol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention and interception trials in inflammatory bowel disease: an international taskforce assessment on clinical trial design.
Sailish Honap, Nelly Agrinier, Joana Torres, Kenneth Croitoru, Sun-Ho Lee, Patrick Netter

Lancet Gastroenterol Hepatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review: Methotrexate-A poorly understood and underused medication in inflammatory bowel disease.
Léa Sequier, Bénédicte Caron, Damien Loeuille, Sailish Honap, Vipul Jairath, Patrick Netter

Aliment Pharmacol Ther· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Difficult-to-treat inflammatory bowel disease: Effectiveness and safety of 4th and 5th lines of treatment.
Bénédicte Caron, Alexandre Habert, Olivier Bonsack, Houda Camara, Elodie Jeanbert, Patrick Netter

United European Gastroenterol J· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stemming the tide with ileocecal Crohn's disease: when is pharmacotherapy enough?
Sophie Vieujean, Paulo Gustavo Kotze, Patrick Netter, Adeline Germain, Edouard Louis

Expert Opin Pharmacother· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An update on the safety of long-term vedolizumab use in inflammatory bowel disease.
Sailish Honap, Patrick Netter, Silvio Danese, Laurent Peyrin-Biroulet

Expert Opin Drug Saf· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Food avoidance and fasting in patients with inflammatory bowel disease: Experience from the Nancy IBD nutrition clinic.
Olivier Bonsack, Bénédicte Caron, Cedric Baumann, Anne Charlotte Heba, Sophie Vieujean, Patrick Netter

United European Gastroenterol J· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of circulating biomarkers of Crohn's disease and spondyloarthritis using Fourier transform infrared spectroscopy.
Pierre Prada, Benjamin Brunel, David Moulin, Lise Rouillon, Patrick Netter

J Biophotonics· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Available Methods for Benefit-risk Assessment: Lessons for Inflammatory Bowel Disease Drugs.
Bénédicte Caron, Ferdinando D'Amico, Vipul Jairath, Patrick Netter, Silvio Danese

J Crohns Colitis· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Landscape of new drugs and targets in inflammatory bowel disease.
Sophie Vieujean, Ferdinando D'Amico, Patrick Netter, Silvio Danese, Laurent Peyrin-Biroulet

United European Gastroenterol J· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory Bowel Disease Patients' Acceptance for Switching from Intravenous Infliximab or Vedolizumab to Subcutaneous Formulation: The Nancy Experience.
Clotilde Remy, Bénédicte Caron, Celia Gouynou, Vincent Haghnejad, Elodie Jeanbert, Patrick Netter

J Clin Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Safety of Ustekinumab and Vedolizumab in Older Patients with Inflammatory Bowel Disease: A Bicentric Cohort Study.
Alice Burgevin, Bénédicte Caron, Alexa Sasson, Amandine Luc, Patrick Netter

J Clin Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Faecal incontinence in inflammatory bowel disease: The Nancy experience.
Simon Kurt, Bénédicte Caron, Celia Gouynou, Patrick Netter, Carolynne J Vaizey

Dig Liver Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific antibodies for the treatment in inflammatory bowel disease: an avenue worth exploring?
Bénédicte Caron, Patrick Netter, Silvio Danese, Laurent Peyrin-Biroulet

Expert Opin Biol Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular Manifestations in Patients with Inflammatory Bowel Disease in the Biologics Era.
Alix Cuny, Lucas Guillo, Cédric Baumann, Patrick Netter, Silvio Danese

J Clin Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models.
Sophie Vieujean, Bénédicte Caron, Vincent Haghnejad, Jean-Yves Jouzeau, Patrick Netter

Int J Mol Sci· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastroenterological safety of IL-17 inhibitors: a systematic literature review.
Bénédicte Caron, Jean-Yves Jouzeau, Pierre Miossec, Nadine Petitpain, Pierre Gillet, Patrick Netter

Expert Opin Drug Saf· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter: treatment with subcutaneous CT-P13 in Crohn's disease patients with intravenous infliximab failure.
Bénédicte Caron, Mathurin Fumery, Patrick Netter, Laurent Peyrin-Biroulet

Aliment Pharmacol Ther· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of and Risk Factors for Colorectal Strictures in Ulcerative Colitis: A Multicenter Study.
Pierre-Antoine Laurain, Lucas Guillo, Ferdinando D'Amico, Patrick Netter, Silvio Danese

Clin Gastroenterol Hepatol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Reforming Biosciences and Health Research: Part I, Funding].
Arnold Migus, Raymond Ardaillou, Patrick Berche, Christian Boitard, Bruno Clément, Patrick Netter

Bull Acad Natl Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-17 Inhibitors and Inflammatory Bowel Diseases: A Postmarketing Study in Vigibase.
Nadine Petitpain, Ferdinando D'Amico, Melissa Yelehe-Okouma, Jean-Yves Jouzeau, Patrick Netter

Clin Pharmacol Ther· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of protective effect of CCR3 blockade during experimental colitis may be related to CCR3 expression by colonic Tregs.
Maroua Ferhat, Julie Hablot, Mahdia Taieb, Fatouma Salem, Patrick Netter

Clin Transl Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Setting up a Virtual Calprotectin Clinic in Inflammatory Bowel Diseases: Literature Review and Nancy Experience.
Ferdinando D'Amico, Patrick Netter, Cedric Baumann, Muriel Veltin, Camille Zallot

J Clin Med· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low Back Pain and Sacroiliitis on Cross-Sectional Abdominal Imaging for Axial Spondyloarthritis Diagnosis in Inflammatory Bowel Diseases.
Marine Fauny, Nicolas Cohen, Caroline Morizot, Sophie Leclerc-Jacob, Daniel Wendling, Patrick Netter

Inflamm Intest Dis· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis